China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about $500 million. The Financial Times had reported in October that WuXi and WuXi ...
A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.
Net profit likely fell 90 percent to 93 percent to between CNY86 million and CNY120 million (USD11.7 million to USD16.4 ...
Nanovaccine achieved tumour inhibition rate of 89.3 per cent when tested on mice with aggressive form of the disease, study finds.
In a move to bolster global health cooperation, China has pledged its unwavering support for the World Health Organization ...
The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...
Professor Paul Hunter from the University of East Anglia notes that almost every child contracts HMPV by five years of age, with reinfections occurring throughout life. “HMPV typically causes ...
The two other vaccines in China’s emergency program, both developed by institutes linked to Sinopharm, and another vaccine from CanSino Biologics, were also shown to be safe and triggered immune ...
Robert F. Kennedy Jr., who awaits confirmation as Donald Trump's Health and Human Services secretary, helped organize mass ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback